UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

Journal of antimicrobial chemotherapy, 2014-01, Vol.69 (1), p.12-20

2014

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance

Antimicrobial Agents and Chemotherapy, 2010-10, Vol.54 (10), p.4253-4261

2010

Link zum Volltext

Verfügbarkeit prüfen

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population

Clinical infectious diseases, 2019-01, Vol.68 (2), p.213-221

2019

Link zum Volltext

Verfügbarkeit prüfen

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

PloS one, 2010-06, Vol.5 (6), p.e10992

2010

Link zum Volltext

Verfügbarkeit prüfen

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2305-2313

2012

Link zum Volltext

Verfügbarkeit prüfen

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

The Journal of infectious diseases, 2009-08, Vol.200 (3), p.453-463

2009

Link zum Volltext

Verfügbarkeit prüfen

Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4522-4524

2012

Link zum Volltext

Verfügbarkeit prüfen

Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral-Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations

Journal of Virology, 2008-11, Vol.82 (21), p.10747-10755

2008

Link zum Volltext

Verfügbarkeit prüfen

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

Journal of Virology, 2003-04, Vol.77 (8), p.4836-4847

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of osteonecrosis and osteoporosis in HIV-1-infected patients

AIDS (London), 2011-09, Vol.25 (15), p.1877-1880

2011

Link zum Volltext

Verfügbarkeit prüfen

Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1

Antimicrobial Agents and Chemotherapy, 2013-09, Vol.57 (9), p.4290-4299

2013

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance

The Journal of infectious diseases, 2005-08, Vol.192 (3), p.456-465

2005

Link zum Volltext

Verfügbarkeit prüfen

Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno-THEO on a Large Clinical Database

The Journal of infectious diseases, 2009-04, Vol.199 (7), p.999-1006

2009

Link zum Volltext

Verfügbarkeit prüfen

Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.934-936

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

Journal of hepatology, 2016-09, Vol.65 (3), p.509-516

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with Past Treatment

The Journal of infectious diseases, 2007-10, Vol.196 (8), p.1177-1179

2007

Link zum Volltext

Verfügbarkeit prüfen

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations

Antimicrobial Agents and Chemotherapy, 2009-11, Vol.53 (11), p.4869-4878

2009

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis

Clinical infectious diseases, 1999-02, Vol.28 (2), p.291-296

1999

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

The Journal of infectious diseases, 2017-08, Vol.216 (3), p.387-391

2017

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Isolates with the Reverse Transcriptase (RT) Mutation Q145M Retain Nucleoside and Nonnucleoside RT Inhibitor Susceptibility

Antimicrobial Agents and Chemotherapy, 2009-05, Vol.53 (5), p.2196-2198

2009

Link zum Volltext

Verfügbarkeit prüfen

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

Journal of acquired immune deficiency syndromes (1999), 2009-11, Vol.52 (3), p.309

2009

Link zum Volltext

Verfügbarkeit prüfen

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors

Scientific reports, 2017-09, Vol.7 (1), p.11559-11, Article 11559

2017

Link zum Volltext

Verfügbarkeit prüfen

Impaired neurocognition in HIV-infected patients: antecedents and treatment

AIDS (London), 2009-08, Vol.23 (13), p.1731-1733

FESSEL, W. Jeffrey

2009

Link zum Volltext

Verfügbarkeit prüfen

Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

Antimicrobial Agents and Chemotherapy, 2002-04, Vol.46 (4), p.1086-1092

2002

Link zum Volltext

Verfügbarkeit prüfen

Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factor

AIDS (London), 2011-11, Vol.25 (18), p.2305-2306

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(94)

Sprache

Englisch
(94)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(77)
Humans
(76)
Life Sciences & Biomedicine
(75)
Infectious Diseases
(46)
Biological And Medical Sciences
(43)
Medical Sciences
(42)
Hiv Infections - Drug Therapy
(36)
Male
(34)
Female
(31)
Adult
(30)
Immunology
(30)
Microbiology
(29)
Middle Aged
(29)
Human Viral Diseases
(28)
Viral Diseases
(28)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(25)
Virology
(25)
Hiv Infections - Virology
(24)
Hiv-1 - Genetics
(24)
Aids/hiv
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing

HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility

Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms

Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine

Minority Human Immunodeficiency Virus Type 1 Variants in Antiretroviral-Naive Persons with Reverse Transcriptase Codon 215 Revertant Mutations

Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease following Different Protease Inhibitor Treatments

Association of osteonecrosis and osteoporosis in HIV-1-infected patients

Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1

HIV-1 Protease and Reverse-Transcriptase Mutations: Correlations with Antiretroviral Therapy in Subtype B Isolates and Implications for Drug-Resistance Surveillance

Predicting the Response to Combination Antiretroviral Therapy: Retrospective Validation of geno2pheno-THEO on a Large Clinical Database

Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector

Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

Prevalence of Darunavir Resistance-Associated Mutations: Patterns of Occurrence and Association with Past Treatment

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations

A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

Human Immunodeficiency Virus Type 1 Isolates with the Reverse Transcriptase (RT) Mutation Q145M Retain Nucleoside and Nonnucleoside RT Inhibitor Susceptibility

Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors

Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors

Impaired neurocognition in HIV-infected patients: antecedents and treatment

Evolution of Primary Protease Inhibitor Resistance Mutations during Protease Inhibitor Salvage Therapy

Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factor

Suchergebnisse filtern